Scout | Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

This grant opportunity aims to speed up the process of bringing cancer detection and prevention tools into clinical use. It focuses on adapting and clinically validating various markers (molecular, cellular, imaging) for cancer-related purposes, such as diagnosis and monitoring treatment responses. The grant supports obtaining specimens from clinical trials to validate these tools, encouraging…

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $150,000

Funding Amount: $150,000

Dates

Opportunity Released: October 10, 2023

Open for Submission: October 10, 2023

Submission Deadline: October 13, 2026

Application Window Closes: October 13, 2026

Keywords

biomarker assays

clinical validation

cancer detection

molecular markers

cellular markers

imaging markers

cancer diagnosis

clinical laboratory

multidisciplinary research

cancer prognosis

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers